Clinical Trial Update: OJO-miR: microRNA Expression in Allergic Conjunctivitis.

View source ↗

Summary

The OJO-miR study investigates microRNA expression in allergic conjunctivitis and is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Conjunctivitis, Allergic | Status: ACTIVE_NOT_RECRUITING